Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Trivano
Alles over “Fabricage van farmaceutische preparaten”
Aandelen in “Fabricage van farmaceutische preparaten”
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Aandeel
Datum
Koers
Evolutie
Even geduld...
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Nieuws over “Fabricage van farmaceutische preparaten”
Toon enkel gratis nieuws
07:57 ·
Evotec Secures $2.9 Million Grant to Advance Early Drug Safety Testing Using Human Stem Cell Technology
· Persbericht
07:57 ·
Evotec Secures $2.9 Million Grant to Advance Early Drug Safety Testing Using Human Stem Cell Technology
· Persbericht
07:30 ·
Lakefront Initiates New €50 Million Share Repurchase Program Following Completion of Initial Share Repurchase Program
· Persbericht
07:30 ·
Lakefront start nieuw aandeleninkoopprogramma ter waarde van €50 miljoen na voltooiing van initieel aandeleninkoopprogramma
· Persbericht
06:12 ·
ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit with SBS Law
· Persbericht
15/11 ·
Viking Therapeutics Highlights Clinical Data from VK2735 Obesity Program at ObesityWeek® 2026
· Persbericht
14/11 ·
Lilly to present new data across Zepbound, Foundayo, EloraTZP and retatrutide at ObesityWeek 2026, moving obesity care beyond the scale
· Persbericht
13/11 ·
Immunic, Inc. Reports Third Quarter 2026 Financial Results and Provides Corporate Update
· Persbericht
12/11 ·
Nektar Therapeutics Announces Third Quarter 2026 Financial Results
· Persbericht
12/11 ·
Atrium Therapeutics Reports Third Quarter 2026 Financial Results
· Persbericht
12/11 ·
Lilly breaks ground in Pennsylvania's Lehigh Valley on a $3.5 billion site to make next-generation obesity medicines, the latest of 10 new U.S. sites since 2020
· Persbericht
12/11 ·
Sanofi: Information concerning the total number of voting rights and shares - October 2026
· Persbericht
12/11 ·
SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of November 16, 2026 in Ardelyx, Inc. Lawsuit - ARDX
· Persbericht
12/11 ·
Tiziana Life Sciences to Present at the Jefferies Global Healthcare Conference 2026 in London
· Persbericht
12/11 ·
A Run of FDA Target Dates Fills the Biotech Calendar From Late November to Year End
· Persbericht
12/11 ·
Investigation of MDGL Reminder: Madrigal Pharmaceuticals, Inc. Investors are Encouraged to Contact Kessler Topaz Meltzer & Check, LLP
· Persbericht
12/11 ·
Ingram Micro Holding Set to Join S&P SmallCap 600
· Persbericht
12/11 ·
ARDX UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Ardelyx (NASDAQ: ARDX) Investors of Securities Class Action Lawsuit Deadline on November 16, 2026
· Persbericht
11/11 ·
Addex Spin-out Neurosterix Closes $105 Million Series B Financing
· Persbericht
11/11 ·
Nektar Therapeutics to Participate in Two Investor Conferences in November
· Persbericht
11/11 ·
Lakefront Biotherapeutics Reports Nine Months 2026 Financial Results and Provides Business Update
· Persbericht
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe